Schedule 13G ownership disclosure

PLIANT THERAPEUTICS INC

Common Stock · CUSIP: 729139105

Event date: 2025-06-30

Filing-level shares
3,737,335
Percent of class
6.1%
  • Morgan Stanley

    Shares: 3,737,335 · Class: 6.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-25-000462
Form type
SCHEDULE 13G
Filer
MORGAN STANLEY
CIK
CIK 895421
Filed
Aug 06, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub